Evidence map›Paper›PMID 25261072›Full record

ArticleBMC genomics2014

The highly polymorphic CYP6M7 cytochrome P450 gene partners with the directionally selected CYP6P9a and CYP6P9b genes to expand the pyrethroid resistance front in the malaria vector Anopheles funestus in Africa.

Jacob M Riveron, Sulaiman S Ibrahim, Emmanuel Chanda, Themba Mzilahowa, Nelson Cuamba, Helen Irving, Kayla G Barnes, Miranda Ndula, Charles S Wondji

Abstract read
In one paragraph

Article in BMC genomics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed.

  1. Article
  2. Spatial Heterogeneity ofJournal of parasitology research · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Functional Validation of Endogenous Redox PartnerInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Contrasting Patterns ofMicroorganisms · 2023
    Article
  16. Article
  17. Review
  18. The buzz in the field: the interaction between viruses, mosquitoes, and metabolism.Frontiers in cellular and infection microbiology · 2023
    Review
  19. Understanding the Intransigence of Malaria in Malawi.The American journal of tropical medicine and hygiene · 2022
    Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jacob M Riveron
Sulaiman S Ibrahim
Emmanuel Chanda
Themba Mzilahowa
Nelson Cuamba
Helen Irving
Kayla G Barnes
Miranda Ndula
Charles S WondjiVector Biology Department, Liverpool School of Tropical Medicine, Pembroke place, Liverpool, L3 5QA, UK. c.s.wondji@liverpool.ac.uk.

Funding

Wellcome Trust 083515/Z/07/ZWellcome Trust 101893
6 · The paper itself

Abstract

backgroundPyrethroid resistance in the major malaria vector Anopheles funestus is rapidly expanding across Southern Africa. It remains unknown whether this resistance has a unique origin with the same molecular basis or is multifactorial. Knowledge of the origin, mechanisms and evolution of resistance are crucial to designing successful resistance management strategies.

resultsHere, we established the resistance profile of a Zambian An. funestus population at the northern range of the resistance front. Similar to other Southern African populations, Zambian An. funestus mosquitoes are resistant to pyrethroids and carbamate, but in contrast to populations in Mozambique and Malawi, these insects are also DDT resistant. Genome-wide microarray-based transcriptional profiling and qRT-PCR revealed that the cytochrome P450 gene CYP6M7 is responsible for extending pyrethroid resistance northwards. Indeed, CYP6M7 is more over-expressed in Zambia [fold-change (FC) 37.7; 13.2 for qRT-PCR] than CYP6P9a (FC15.6; 8.9 for qRT-PCR) and CYP6P9b (FC11.9; 6.5 for qRT-PCR), whereas CYP6P9a and CYP6P9b are more highly over-expressed in Malawi and Mozambique. Transgenic expression of CYP6M7 in Drosophila melanogaster coupled with in vitro assays using recombinant enzymes and assessments of kinetic properties demonstrated that CYP6M7 is as efficient as CYP6P9a and CYP6P9b in conferring pyrethroid resistance. Polymorphism patterns demonstrate that these genes are under contrasting selection forces: the exceptionally diverse CYP6M7 likely evolves neutrally, whereas CYP6P9a and CYP6P9b are directionally selected. The higher variability of CYP6P9a and CYP6P9b observed in Zambia supports their lesser role in resistance in this country.

conclusionPyrethroid resistance in Southern Africa probably has multiple origins under different evolutionary forces, which may necessitate the design of different resistance management strategies.

Indexed as

Polymorphism, GeneticAfricaAnimalsAnimals, Genetically ModifiedAnophelesCytochrome P-450 Enzyme SystemDrosophila melanogasterDrug ResistanceFemaleGene Expression ProfilingGenetic VariationGenomeHaplotypesInsecticidesKineticsMalariaCytochrome P-450 Enzyme SystemInsecticidesPyrethrinsRecombinant Proteins

Identifiers

PMID25261072
PMCPMC4192331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.